Compare STVN & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STVN | CHE |
|---|---|---|
| Founded | 1949 | 1970 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 6.2B |
| IPO Year | N/A | N/A |
| Metric | STVN | CHE |
|---|---|---|
| Price | $15.88 | $472.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $23.75 | ★ $555.50 |
| AVG Volume (30 Days) | ★ 1.0M | 170.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 0.40% | ★ 0.51% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.42 | $5.91 |
| Revenue Next Year | $9.61 | $6.06 |
| P/E Ratio | $26.70 | ★ $24.96 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.91 | $408.42 |
| 52 Week High | $28.00 | $623.61 |
| Indicator | STVN | CHE |
|---|---|---|
| Relative Strength Index (RSI) | 40.83 | 68.51 |
| Support Level | $15.43 | $443.33 |
| Resistance Level | $16.69 | $458.93 |
| Average True Range (ATR) | 0.99 | 11.60 |
| MACD | 0.19 | 3.31 |
| Stochastic Oscillator | 60.60 | 85.18 |
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.